Cargando…
Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance
Monoclonal gammopathy of renal significance (MGRS) defines renal diseases resulting from the nephrotoxic effects of monoclonal proteins secreted from non-malignant clonal B cells or plasma cells, that do not meet criteria for multiple myeloma, Waldenstrom’s macroglobulinemia, chronic lymphocytic leu...
Autores principales: | Lee, Holly, Duggan, Peter, Neri, Paola, Tay, Jason, Jimenez-Zepeda, Victor H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328037/ https://www.ncbi.nlm.nih.gov/pubmed/30671213 http://dx.doi.org/10.4084/MJHID.2019.007 |
Ejemplares similares
-
Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen
por: Quattrocchio, Giacomo, et al.
Publicado: (2020) -
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021) -
Monoclonal gammopathy of renal significance: case report
por: Fonseca, Gabriela Spacek da, et al.
Publicado: (2018) -
Monoclonal gammopathy of renal significance: Diagnostic workup
por: Correia, Sofia O, et al.
Publicado: (2017) -
Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond
por: Menè, Paolo, et al.
Publicado: (2020)